The market size was $740 Million in 2020, rising to $900 Million by 2025, and is forecasted to surpass $1,540 Million by 2035. Revenue growth is fueled by expanding aging populations, product launches in absorbable technology, and higher incidence of nasal bleeding-related cases. The CAGR is projected at 5.5% across the analysis period, with a clear upward trend reflecting sustained technology adoption and wider healthcare access across regions.

Read More - https://bussinessinsights.com/research-report/us-epistaxis-device

Hospitals remain the primary segment, holding the dominant market share for epistaxis device usage in the US, reflecting advanced infrastructure and comprehensive emergency care demand. Clinics form the second-largest share, as increased outpatient procedures and ENT specialty centers expand in urban areas. Homecare application is steadily rising in share as ease of device use and demographic shifts encourage at-home treatment of minor to moderate bleeds, especially for the elderly population.

Request Free Sample- https://bussinessinsights.com/request/medical-devices/us-epistaxis-device

Frequently Asked Questions

Who are the key players in US Epistaxis Device industry?
The top five key players in the US Epistaxis Device industry are Smith & Nephew, Stryker, Medtronic, Teleflex, and Summit Medical. These companies lead the market through innovation in nasal packing products, surgical devices, and minimally invasive epistaxis treatment solutions, maintaining strong distribution networks and robust clinical support.

What is the US Epistaxis Device growth?
The US Epistaxis Device market is seeing robust growth, driven by the increasing prevalence of chronic nasal conditions and an aging population. Recent developments by Smith & Nephew in minimally invasive nasal packing devices have contributed strongly, with the industry expected to grow at a compound annual rate above 6% through 2028.

Which segment accounted for the largest US Epistaxis Device share?
The nasal packing devices segment holds the largest share in the US Epistaxis Device market. Widely used in emergency departments and ENT clinics for rapid bleeding control, these devices are favored due to their efficacy, quick application, and support in both anterior and posterior nosebleeds.

Thanks & Regards,
Manisha C
sales@bussinessinsights.com